Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Trends in Immunology|January 28, 2023
Obesity and dysregulated innate immune responses: impact of micronutrient deficienciesFrank Vrieling, Rinke Stienstra
Adipocyte|November 1, 2024
Lipid accumulation in adipose tissue-resident iNKT cells contributes to an inflammatory phenotypeImogen Morris, Frank Vrieling, Annemieke Bouwman, et al.
STAR Protocols|October 9, 2025
Protocol for measuring cellular energetics through noncanonical amino acid tagging in human peripheral blood and murine tissue immune cellsFrank Vrieling, Hendrik J P van der Zande, Manon Dumont, et al.
Plos Biology|August 26, 2022
Macrophages take up VLDL-sized emulsion particles through caveolae-mediated endocytosis and excrete part of the internalized triglycerides as fatty acidsLei Deng, Frank Vrieling, Rinke Stienstra, et al.
Plos Pathogens|April 19, 2019
Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunctionFrank Vrieling, Louis Wilson, Patrick C N Rensen, et al.
Ebiomedicine|May 22, 2018
Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid ProfileFrank Vrieling, Katharina Ronacher, Léanie Kleynhans, et al.
Plos One|February 10, 2015
The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosisEkta Lachmandas, Frank Vrieling, Louis G Wilson, et al.
Heliyon|February 16, 2022
The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal modelBenthe van der Lugt, Maartje C P Vos, Mechteld Grootte Bromhaar, et al.
Scientific Reports|April 29, 2020
Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomicsFrank Vrieling, Sarantos Kostidis, Herman P Spaink, et al.
Scientific Reports|December 12, 2019
Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatmentFrank Vrieling, Bachti Alisjahbana, Edhyana Sahiratmadja, et al.
Pageof 3